<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11863027</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.337</article-id><article-id pub-id-type="other">EPP0116</article-id><article-id pub-id-type="pii">S0924933824003377</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Presentation</subject></subj-group></article-categories><title-group><article-title>SARS-CoV-2 infection and psychological distress : a prospective sero-survey in southern Switzerland</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Bano</surname><given-names>B.</given-names></name><xref rid="aff0664" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor0198" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Sculco</surname><given-names>C.</given-names></name><xref rid="aff0665" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Piumatti</surname><given-names>G.</given-names></name><xref rid="aff0666" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Amati</surname><given-names>R.</given-names></name><xref rid="aff0664" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Purgato</surname><given-names>M.</given-names></name><xref rid="aff0667" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Albanese</surname><given-names>E.</given-names></name><xref rid="aff0664" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="aff0664">
<sup>1</sup>
<institution>Institute of Public Health, Universit&#x000e0; della Svizzera italiana</institution>
</aff><aff id="aff0665"><sup>2</sup>Institute of Public Health, <institution>Universita&#x02019; della Svizzera italiana</institution>, <city>Lugano</city>, <country>Switzerland</country></aff><aff id="aff0666"><sup>3</sup>Fondazione Agnelli, <city>Turin</city></aff><aff id="aff0667"><sup>4</sup>Department of Neurosciences, Biomedicine, Movement Sciences, <institution>University of Verona</institution>, <city>Verona</city>, <country>Italy</country></aff><author-notes><corresp id="cor0198"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="312">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S151</fpage><lpage>S151</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824003377a.pdf"/><abstract><sec id="sec1188"><title>Introduction</title><p>The COVID-19 pandemic has had an impact on the mental health of the population that, to some extent, may be due to the neurotropism of SARS-CoV-2. However, evidence is extremely sparse on the prospective association between serological evidence of COVID-19 infection and psychological distress.</p></sec><sec id="sec1189"><title>Objectives</title><p>We aimed to explore the prospective association between seropositivity and psychological distress &#x02013; assessed by symptoms of depression, anxiety and stress &#x02013; in the general adult population in southern Switzerland. Further, we investigated whether this association varied over time and between pandemic waves.</p></sec><sec id="sec1190"><title>Methods</title><p>We used data from 305 adults who participated in the Corona Immunitas Ticino (CIT) prospective sero-survey cohort study. We tested the association between serologically confirmed SARS-COV-2 infection at baseline (June&#x02013;December 2020) and depression, anxiety and stress scores as measured by the DASS-21 scale at three time points between December 2020 and March 2021, also taking into account for sociodemographic characteristics (age, gender, education level, presence of chronic diseases, smoking, obesity).</p></sec><sec id="sec1191"><title>Results</title><p>In our sample, 84.3% (mean age of 51.30, SD= &#x000b1; .93) were never infected. Seropositive participants were significantly younger on average (M=46.90, SD= &#x000b1;2.00, P= .04). At the first follow-up (see Table 1), seropositive participants had higher rates of mild conditions for depression (OR= .64; P= .014) and anxiety (OR= .50; P= .030), than seronegatives. Overall, after the 6-month follow-up, seropositive participants had significantly lower rates of mild conditions for DASS-21 subscales. In addition, prevalence of mild conditions for depression, anxiety and stress decreased more rapidly over time among infected vs. never infected (see Figure 1). Older age and the presence of chronic diseases were associated with mild anxiety (OR= .97; P= .013; OR=3.47; P= .001) and stress (OR= .96; P= .003; OR= 2.56; P= .010).<table-wrap position="anchor" id="tab3"><label>Table 1.</label><caption><p>Associations (Odds Ratios) between seropositive immunological status and mental health between December 2020 and March 2021 in Ticino, southern Switzerland (N=305)</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/></colgroup><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">DASS-21 defined mild condition</th><th align="center" valign="middle" rowspan="1" colspan="1">OR</th><th align="center" valign="middle" rowspan="1" colspan="1">P value</th><th align="center" valign="middle" rowspan="1" colspan="1">CI (95%)</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Depression</td><td align="center" valign="middle" rowspan="1" colspan="1">0.641</td><td align="center" valign="middle" rowspan="1" colspan="1">0.014</td><td align="center" valign="middle" rowspan="1" colspan="1">0.449 &#x02013; 0.914</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Anxiety</td><td align="center" valign="middle" rowspan="1" colspan="1">0.502</td><td align="center" valign="middle" rowspan="1" colspan="1">0.030</td><td align="center" valign="middle" rowspan="1" colspan="1">0.270 &#x02013; 0.936</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Stress</td><td align="center" valign="middle" rowspan="1" colspan="1">0.712</td><td align="center" valign="middle" rowspan="1" colspan="1">0.113</td><td align="center" valign="middle" rowspan="1" colspan="1">0.468 &#x02013; 1.083</td></tr></tbody></table><graphic xlink:href="S0924933824003377-TABU0003" position="anchor"/></alternatives><table-wrap-foot><p>Note. Generalized estimating equation models results. Co-variates include time, age, gender, chronic diseases, obesity, smoking and education level.</p></table-wrap-foot></table-wrap></p></sec><sec id="sec1192"><title>Conclusions</title><p>Our results provide new evidence on the association between COVID-19 seropositivity and poor mental health and underline the public health implications of the pandemic because the number of infected individuals largely exceed the 770 million of recorded COVID-19 (symptomatic) cases.</p></sec><sec id="sec1193"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>